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ABSTRACT
The mechanism by which micro (mi)RNAs control
their target gene expression is now well understood.
It is however less clear how the level of miRNAs them-
selves is regulated. Under specific conditions, abun-
dant and highly complementary target RNA can trig-
ger miRNA degradation by a mechanism involving
nucleotide addition and exonucleolytic degradation.
One such mechanism has been previously observed
to occur naturally during viral infection. To date, the
molecular details of this phenomenon are not known.
We report here that both the degree of complemen-
tarity and the ratio of miRNA/target abundance are
crucial for the efficient decay of the small RNA. Us-
ing a proteomic approach based on the transfection
of biotinylated antimiRNA oligonucleotides, we set
to identify the factors involved in target-mediated
miRNA degradation. Among the retrieved proteins,
we identified members of the RNA-induced silencing
complex, but also RNA modifying and degradation
enzymes. We further validate and characterize the
importance of one of these, the Perlman Syndrome
3′-5′ exonuclease DIS3L2. We show that this protein
interacts with Argonaute 2 and functionally validate
its role in target-directed miRNA degradation both
by artificial targets and in the context of mouse cy-
tomegalovirus infection.
INTRODUCTION
Among the various classes of small regulatory RNAs, miR-
NAs represent one of the most studied in mammals. They
act as guides to recruit Argonaute proteins (Ago) to target
mRNAs, resulting in translation inhibition and reduced sta-
bility (1). These tiny regulators are involved in awide variety
of biological processes (2,3), and their aberrant expression
can be the cause of genetic diseases and/or cancers (4,5).
Consequently, their synthesis and turnover must be tightly
controlled. Briefly, miRNAs are transcribed in the nucleus
as a primary transcript (pri-miRNA) containing a hairpin
structure, which is recognized and cleaved by the RNase III
Drosha. This cleavage generates a precursor miRNA (pre-
miRNA) which will be exported to the cytoplasm, where a
second cleavage by the RNase III Dicer gives rise to a ≈22
nucleotides (nt) miRNA duplex (1). One strand of the du-
plex (guide strand) is loaded in the RISC (RNA-Induced
Silencing Complex) and becomes the active miRNA, while
the second strand (passenger strand) is often degraded.
miRNA biogenesis is regulated both transcriptionally
and post-transcriptionally by differentmechanisms control-
ling the level of pri-miRNA transcription, the activity or
the accessibility of Drosha and/or Dicer or the stability of
the pre-miRNA (1). One of the best described example of
miRNA biogenesis regulation involves the LIN28 protein,
which negatively impacts the synthesis of Let-7 miRNA (6–
11). LIN28 reduces the cleavage activity of both Drosha
and Dicer, at respectively the pri-Let-7 and the pre-Let-
7 levels (6–8). LIN28 also recruits the Terminal-Uridylyl-
Transferases TUT4/TUT7 (9,10), which uridylate pre-Let-
7 leading to its subsequent degradation by the exonuclease
DIS3L2 (11).More recently, TUT4 and TUT7were also de-
scribed to have amore widespread role in the control of pre-
miRNA degradation via a mechanism involving the RNA
exosome (12).
Mature miRNAs, which represent the active end prod-
ucts of this biogenesis were long thought to be very sta-
ble molecules with half-lives ranging from hours to days
(13,14). But recently, several examples showed that they
are also subjected to active regulation. In this case, mod-
ifications of the small RNA play essential roles to influ-
ence its stability or function. For example, miR-122 mono-
adenylation by GLD-2 (TUT2) stabilizes this miRNA in
mammals (15). At the opposite, miR-26a is no longer func-
tional as a consequence of its uridylation by ZCCHC11
(TUT4) (16). In addition, accelerated miRNA turnover has
been reported. This is especially true for biological situ-
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ations that require rapid changes in gene expression (i.e.
cell cycle, light-dark transitions) (17–19), or during viral in-
fections (20–22). Moreover, the presence of a highly com-
plementary target can induce miRNA degradation via a
mechanism involving tailing (3′ addition of non-templated
nucleotides) followed by trimming of the miRNA (13,23).
From now on, we will refer to this phenomenon as target
RNA-directed miRNA degradation (TDMD) according to
a recent report from the Grosshans laboratory (24).
In several organisms, small RNA species are usu-
ally protected from degradation by addition of a 2’O-
methyl group at their 3′ extremity by the methyltrans-
ferase HEN1 (23,25). In hen-1 mutant plants and flies,
the lack of a 2’O-methylated 3′ terminal residue results in
3′ uridylation/adenylation and subsequent 3′ to 5′ degra-
dation of small interfering (si)RNAs (and plant miR-
NAs) (23,26). As opposed to siRNAs or plant miR-
NAs, Drosophila and mammals miRNAs are not 3′ pro-
tected and usually present only a partial complementarity
with their target RNAs. This explains why a near-perfect
miRNA/target complementarity (involving an extensive
pairing of the 3′ region of the miRNA) coupled to a high
abundance of the target seems to trigger miRNA degrada-
tion rather than mRNA regulation (23). Therefore, TDMD
could represent a potential and powerful spatiotemporal
way to regulatematuremiRNAaccumulation. Accordingly,
TDMD has been observed in vivo in the context of mouse
cytomegalovirus (MCMV) infection. Indeed, MCMV ex-
presses an abundant viral transcript (m169), which local-
izes to the cytoplasm and induces degradation of the cellu-
lar miR-27a and b (20,21). To date, the molecular details of
the process and the cellular enzymes involved in this mech-
anism are unknown.
In this study, we developed a biochemical approach
that allowed us to induce TDMD in cell lines and to un-
cover the identity of the cellular factors responsible for
the target-induced degradation of mature miRNAs. We re-
trieved known components of the RISC as well as several
putative candidates for themiRNAmodification and degra-
dation. Among those, we identified the Terminal-Uridylyl-
Transferase TUT1 and the 3′-5′ exoribonuclease DIS3L2.
We confirmed that these two proteins interact with Arg-
onaute 2 and together in an RNA-dependent manner. Al-
though we could not assign a direct role to TUT1 in the
TDMDprocess, most likely because of the redundancywith
other TUTases, we could observe that impairing DIS3L2
activity leads to a reduced degradation of miRNAs in hu-
man cells, but also in mouse cells infected with MCMV, a
natural inductor of TDMD.
MATERIALS AND METHODS
Plasmids, cloning and mutagenesis
DIS3L2 was amplified from HeLa total cDNA whereas
cDNA clones (Thermo Scientific) were used as template for
TUT1 (Accession BC128263), mouse mTUT1 (Accession
BC025499), mouse mDIS3L2 (Accession BC036177) and
mouse mAGO2 (Accession BC129922). TUT2, TUT4 and
TUT7 were amplified from the plasmids Flag-TEVAP-
TUT2, -TUT4 and -TUT7 provided byNarryKim.Human
AGO2 was re-amplified from the pIRESneo-FLAG/HA-
AGO2 vector (Addgene). The vector expressing GFP-MBP
was a gift from E. Izaurralde. To generate GFP fusion pro-
teins, TUT1 (BglII/EcoRI), DIS3L2 (BglII/BamHI),
mTUT1 (BglII/EcoRI), mDIS3L2 (EcoRI/KpnI),
TUT2 (EcoRI/BamHI), TUT4 (XhoI/SmaI) and TUT7
(XhoI/BamHI) were each cloned in the pEGFP-C2 expres-
sion vector (Clontech) using the restriction sites indicated
in parentheses. For HA-tagged proteins, the pcDNA3.1(+)
vector (Invitrogen) was first modified by mutagenesis to
insert the coding sequence of the HA-tag 5′ of theMCS cas-
sette. Then, AGO2 (EcoRI/NotI), mAGO2 (EcoRI/NotI),
TUT1 (EcoRI/NotI), mTUT1 (EcoRI/NotI), DIS3L2
(BamHI/NotI) and mDIS3L2 (EcoRI/NotI) were in-
serted between the indicated restriction sites. The catalytic
mutants of DIS3L2 (D391N, D392N) and mDIS3L2
(D389N) were generated by mutagenesis. For the luciferase
reporters, m169–3′ UTR or SH fragment was cloned in the
pcDNA3.1 vector using EcoRV restriction site. Mutation
in the seed region was then done by mutagenesis. To
concatamerize the SH region, SH fragments were amplified
with the insertion of different cloning sites, then treated for
multiple ligation before being re-amplified and cloned as
described above. Finally, the F-Luc coding sequence was
inserted in pcDNA-m169 versions using NheI/KpnI. All
the sequences of the cloning and mutagenesis primers are
available in Supplementary Table S2.
Cell culture and transfection
HeLa cells, Hepa 1.6 cells and HEK293 cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% (v/v) fetal calf serum at 37◦C in a hu-
midified 5%CO2 atmosphere. For co-immunoprecipitation,
HeLa and Hepa cells were transfected with a mixture con-
taining plasmids expressing HA-tagged and GFP-tagged
protein using the Turbofect reagent (Thermo Scientific).
For RNA-immunoprecipitation, HeLa cells (15 × 106 cells
in 15-cm plates) were transfected with 60 g of plasmid
expressing GFP-tagged protein. The day after, cells were
divided and re-seeded in two 15-cm plates. After 10 h,
cells were retransfected with either control antimiRNA di-
rected against the Caenorhabditis elegans specific miR-67
(antimiR-67) or antimiR-27 (or -16) at a final concen-
tration of 10 nM using lipofectamine 2000 (Invitrogen).
The immunoprecipitation was performed 16 h after the
last transfection. For RNAi (DIS3L2 and TUT1), HeLa
cells were transfected twice (at day 1 and day 2) with 100
nM siRNA using Dharmafect-3 (Dharmacon) (siRNA se-
quences are listed in Supplementary Table S2) or 50 nM
eachwhen co-knocked-down. On day 3, cells were re-seeded
to be at 50% confluence and allowed to adhere. Then,
HeLa cells were transfected with 5 nM antimiRNAs us-
ing lipofectamine 2000. Samples were collected 16 h af-
ter the antimiRNA transfection. For overexpression exper-
iment, HEK293 cells were first transfected with 5 g of the
indicated plasmid using Lipofectamine 2000. The day af-
ter, cells are re-seeded, retransfected with the antimiRNA
oligoribonucleotides and collected as described above. For
luciferase assay, HeLa cells were seeded in 48-well plates
and transfected with a mixture containing 25 ng of both
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R-Luc and F-Luc reporters using Lipofectamine 2000. To
overexpress the luciferase reporters, cells were seeded in 12-
well plates, and transfected with mixtures containing 100
ng of the R-Luc transfection control, 0.375, 0.750 or 1.5
g of the F-Luc reporters and empty plasmid to have equal
amounts of DNA. Samples were analyzed 24 hours post-
transfection.
Streptavidin affinity chromatography
For the mass spectrometry analysis, HeLa cells were grown
in 500 cm2 plates to reach 50–60% confluence and then
biotinylated antisense 2’O methylated oligoribonucleotides
were transfected using the calcium-phosphate method at
the indicated concentrations. Up to five independent exper-
iments were performed using 4 plates per samples. 48 hpi,
cells were collected and resuspended in lysis buffer (50 mM
Tris HCl [pH 7.4], 150 mMNaCl, 0.02% sodium azide, 100
g/ml PMSF, 1% NP40), supplemented with Complete-
EDTA-free Protease Inhibitor Cocktail (Roche). After ly-
sis, the samples were cleared by 15 min centrifugation at
4000 g and 4◦C. Then, 200 l of streptavidin-beads (Dyn-
abeads MyOne Streptavidin C1, Invitrogen) were prepared
in RNase-free conditions according to the manufacturer’s
protocol and added to each sample. Samples were incu-
bated for 30min at 4◦C under rotation and then, beads were
washed 5 times in 0.1× SSC. Finally, 1/5 of the sample was
treated with phenol-chloroform to extract total RNA, 1/5
was used for western blot and 3/5 served formass spectrom-
etry analysis by nanoLC-MS/MS.
For smaller scale experiments, the protocol remained the
same except that HeLa cells were seeded in two 15-cm
plates, lysed in 1 ml lysis buffer and incubated with 40 l
of streptavidin beads. 50% of the sample were dedicated to
RNA analysis whereas the second half served for western
blotting.
Immunoprecipitation
HeLa cells were harvested, washed twice with ice-cold
phosphate-buffered saline (1× PBS), and resuspended in 1
ml ofNET buffer (50mMTrisHCl [pH 7.4], 150mMNaCl,
1 mM EDTA, 0.1% Triton), supplemented with Complete-
EDTA-free Protease Inhibitor Cocktail (Roche). Cells are
lysed by three 15 s sonication followed by 30min incubation
on ice and debris are removed by 15 min centrifugation at
16 000 g and 4◦C. If required, lysates are treated 30min with
100 g/ml of RNase A and then re-cleared by centrifuga-
tion. An aliquot of the cleared lysates (50 l) is kept aside
as protein Input and 50 l additional aliquot for RNA In-
put when needed. Polyclonal anti-GFP antibodies (a kind
gift from E. Izaurralde) or AGO2 monoclonal antibodies
(kindly provided by G. Meister) are added and samples are
incubated for 1 h at 4◦C under rotation (18 rpm). Then, 50
l of Protein-G-Agarose beads (Roche) were added and the
samples were rotated similarly for 1 h. After three washes in
NET buffer and a fourth wash in NET buffer without Tri-
ton, bound proteins are elutedwith 100l of protein sample
buffer (100 mM Tris HCl [pH 6.8], 4% SDS, 20% glycerol,
0.2 M DTT, 0.5% bromophenol blue), and/or bound RNA
by phenol/chloroform extraction.
Nucleocytoplasmic fractionation and subsequent immunopre-
cipitation
The cytoplasmic and nuclear fractions were separated fol-
lowing the protocol established by Lim and collaborators
(27). Briefly, 10 × 106 HeLa cells were harvested, washed
twice with ice-cold 1× PBS, resuspended in 500 l of lysis
buffer (50 mM Tris HCl [pH 7.4], 140 mM NaCl, 1.5 mM
MgCl2, 0.1% Igepal CA-630) and incubated for 5 min on
ice. After 10 min of centrifugation at 2000 g and 4◦C, the
supernatant (cytoplasmic fraction) was collected and put
aside. The pellet was then washed twice with wash buffer
(50 mM Tris HCl [pH 7.4], 140 mMNaCl, 1.5 mMMgCl2)
at 2200 g for 5 min at 4◦C. After resuspension in 300 l of
lysis buffer followed by sonication, the samples were spun at
16 000 g for 15 min at 4◦C. The supernatant (nuclear frac-
tion) was then collected. The concentration of each sample
was measured using the DC protein assay kit (Bio-rad).
When the cytoplasmic fraction was followed by immuno-
precipitation, an aliquot was kept aside as input and the
volume of the fraction was increased to 1 ml. Then the sam-
ples were rotated with 25 l of GFP-Trap-A beads (Chro-
motek) during 45 min at 4◦C. After three washes with the
lysis buffer and one additional with the wash buffer, bound
proteins were eluted with 100 l of protein sample buffer.
Luciferase assay
HeLa cells, tranfected with Luciferase reporters 24 h be-
fore, were washed in PBS, lysed with passive lysis buffer
(Promega) and assayed for firefly and Renilla luciferase
activities, using the dual-luciferase reporter assay system
(Promega) and a luminescence module (Glomax, Promega)
according to the manufacturer’s instructions. The relative
F-Luc reporter activity was obtained by first normalizing
to the transfection control (Renilla activity), and then, to
the firefly activity obtained for the reporter without m169-
UTR, which was arbitrarily set to 100.
RNA extraction and northern blot
Total RNA was extracted using Tri-Reagent Solution
(MRC, Inc) according to the manufacturer’s instructions
except the precipitation step, which was done in presence
of 3 volumes absolute ethanol and 0.05 volumes 3 MNaAc
[pH 5].
Northern blotting was performed on 10 to 15 g of to-
tal RNA. RNA was resolved on a 17.5% urea-acrylamide
gel of 20 cm in length, transferred onto Hybond-NX
membrane (GE Healthcare). RNAs were then chemically
cross-linked to the membrane during 90 min at 65◦C
using 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hy-
drochloride (EDC) (Sigma). Membranes were prehy-
bridized for 1 h in PerfectHybTM plus (Sigma) at 50◦C.
Probes consisting of oligodeoxyribonucleotides (containing
LockedNucleic Acids for the detection ofmiR-27 andmiR-
16 tailed/trimmed isoforms) (see Supplementary Table S2)
were 5′-end labeled using T4 polynucleotide kinase (Fer-
mentas) with 25Ci of [ -32P]dATP. The labeled probewas
hybridized to the blot overnight at 50◦C. The blot was then
washed twice at 50◦C for 20 min (5× SSC/0.1% SDS), fol-
lowed by an additional wash (1× SSC/0.1% SDS) for 5min.
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Northern blots were exposed to phosphorimager plates and
scanned using a Bioimager FLA-5100 (Fuji).
Antibodies for western blot analysis
Antibodies were used at the following dilutions: mouse anti-
GFP antibodies (1:2000) and anti-HA-Peroxidase (1:5000)
were purchased from Roche. Rat anti-AGO2 monoclonal
antibody (1:200), rat anti-AGO1 monoclonal antibody
(1:10) and rat anti-TNRC6B antibody (1:20) were kindly
provided by G. Meister. Rabbit anti-DIS3L2 (1:1000) is
a gift from A. Dziembowski and rabbit anti-STARPAP
(TUT1) was kindly provided by R.A. Anderson and used
at 1:3300. Rabbit anti-DIS3 (1:1000), rabbit anti-TUT7
(1:500), mouse anti-tubulin (1:5000), anti-mouse, anti-rat
and anti-rabbit secondary antibodies (1:10000) were pur-
chased from Sigma-Aldrich. Rabbit anti-XRN2 (1:500),
anti-EXOSC3 (1:500), anti-RRP6 (1:3000) and mouse anti-
Histone H3 (1:5000) were purchased from Abcam. Rabbit
anti-XRN1 (1:2000) is from Bethyl laboratories.
MCMV infection of Hepa 1.6 cells
Hepa 1.6 cells were seeded in 6-well plates (5 × 105
cells/well) at day 0, and then transfected at day 1 with 4
g of indicated plasmids using lipofectamine 2000. On day
2, cells were counted and infected accordingly withMCMV
at MOI 1 after centrifugal enhancement at 18◦C and 800 g
for 30 min. Media was replaced after 1 h of infection. RNA
samples were then collected at the indicated time points.
Real time RT-PCR analysis
The quantitative real-time PCR analysis was performed us-
ing Roche LightCycler 480 II. Prior to reverse transcrip-
tion reaction, 1 g of total RNA was treated with DNase
I (Fermentas) according to the provider’s instructions. Re-
verse transcription reaction was performed using miScript
reverse transcription II kit (Qiagen) according to the man-
ufacturer’s instructions. The resulting cDNA was PCR am-
plified with Maxima SYBR green kit (Fermentas) in 10 l
reaction volume. For the analysis of miRNA expression, the
mature sequence of each miRNA was used to design the
forward primer and the miScript universal primer (Qiagen)
was used as reverse primer. Forward and reverse primers
were used respectively at 0.5 M and 0.7×. For mRNA
analysis 0.25 M of each forward and reverse primers were
used. The PCR programwas composed of an initial denatu-
ration step at 95◦C for 10 min followed by 44 cycles at 95◦C
for 15 s, 55◦C for 30 s and 72◦C for 30 s including melting
curve analysis. Data were analyzed as described previously
(28).
RESULTS
Target RNA inducesmiRNAdecay in a non-cooperativeman-
ner
The ectopic expression of the m169 transcript using an ade-
noviral vector is sufficient to induce degradation of both
miR-27a and miR-27b (20), thus indicating that no other
MCMV-encoded factor is needed to tail and trim these
miRNAs. Because it appears that both miRNAs are tar-
geted indifferently, and since we will extensively refer to
these miRNAs in the manuscript, we will refer to bothmiR-
27a and b using the generic term miR-27.
It was clearly shown that the two main features required
to induce TDMD of a miRNA are an extensive pairing and
an abundant target (23). To gain understanding in the sen-
sitivity of the balance between a classical miRNA response
and the triggering of TDMD, we built luciferase reporters
carrying the m169 transcript full 3′ UTR, a shorter ver-
sion of it (termed SH and comprising≈200 nucleotides sur-
rounding miR-27 binding site), or repetitions of the SH se-
quence to increase the number of target sites (Figure 1A).
All versions of the luciferase reporter displayed translation
inhibition (Figure 1B, Supplementary Figure S1A). Fur-
thermore, the level of repression increased with the number
of repetitions of the SH sequence and thus with the num-
ber of miR-27 binding sites, due to a cooperative effect of
miRNAs as previously reported (29–31). This effect could
be slightly but significantly reverted by inserting mutations
in the miR-27 seed-match as shown previously (20) and re-
flects the contribution of miR-27 in the repression of the
reporters. Indeed, the m169 transcript possesses several pu-
tative binding sites for other miRNAs, which could explain
that the reporters bearing mutation in the miR-27 bind-
ing site are never completely derepressed. Transfecting in-
creasing amounts of reporters did not alter the efficiency of
miRNA-mediated repression (Supplementary Figure S1B),
while overexpression of the reporter constructs allows the
induction of miR-27 tailing as assessed by the detection
of bands migrating slower than the four majors isoforms
of miR-27 (Figure 1C, Supplementary Figure S1C). Never-
theless, increasing the number of miRNA binding sites did
not cause a greater impact on miR-27 tailing than the sin-
gle binding site contained in m169 (Figure 1C). Thus, as
opposed to miRNA-mediated repression, which exhibits a
cooperative effect, TDMD appears to be a non-cumulative
phenomenon.
A high complementarity between the miRNA and its
target is a prerequisite to induce TDMD and it was pre-
viously shown in Drosophila that only little bulges (≈3
nt) can be tolerated (23). To understand how a m169-
like binding site can trigger tailing-trimming with a 6-nt
bulge, we transfected HeLa cells with increasing amounts
of 2’O-methylated antisense oligoribonucleotides (antimiR-
NAs) presenting either a perfect complementarity with
miR-27 (antimiR-27) or mimicking the interaction with
m169 (m169-like, Figure 1D) since it was described that an-
timiRNAs are sufficient to recapitulate TDMD in cells (23).
Northern blot analysis of miR-27 expression showed that
a 100-fold more of the m169-like compared to antimiR-27
oligoribonucleotide was needed to induce TDMD (Figure
1E).
In addition, we confirmed the importance of a strong
pairing in the 3′ of the miRNA by inserting mismatches in
the antimiRNA oligoribonucleotide (Figure 1D). A single
mismatch in the position exactly opposite the 3′ proximal
nucleotide in the miRNAwas sufficient to abrogate TDMD
(Figure 1F). In addition, increasing the pairing strength 3′
of the bulge (position 15) by replacing a G-U by a G-C pair
is enough to increase TDMD efficiency (Figure 1G). Thus,
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Figure 1. Characterization of m169-miR27 features triggering TDMD. (A) Reporters containing the 3′ UTR of m169 transcript or single/multiple shorter
(SH) region (blue square) containing miR-27 binding site (red square). (B) Relative expression of the reporters described in (A) and containing either an
intact miR-27 binding site (WT) or mutations in the seed (mut) by luciferase assay. Each F-Luc coding reporter was transfected into HeLa cells together
with a plasmid coding for the Renilla luciferase (R-Luc) as transfection control. The F-Luc activities were normalized to those of Renilla and arbitrarily
set at 100 in absence of 3′ UTR (F-Luc). Mean values +/- standard deviations from three independent experiments are shown. (Student t-test *P <
0.05, **P < 0.01, n = 3 biological replicates). (C) Analysis of miR-27 expression by northern blot when the reporters are overexpressed. U6 serves as
loading control. (D) Sequences and pairing between miR-27 and the antimiRNAs used in this study. AntimiR-27 is in purple and m169-like is in blue.
Modifications introduced in the pairing are in lowercase. (E–G) Northern blots analyzing miR-27 accumulation profil upon antimiRNA transfection in
HeLa cells. Control: antimiR-67. U6 serves as loading control.
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TDMD in mammals requires an extensive 3′ pairing be-
tween themiRNAand its target.However, the ratio between
the miRNA and its target is important and this probably re-
strains the number of naturally occurring targets triggering
miRNA tailing-trimming. Indeed, even if an m169-like in-
teraction can trigger TDMD, the size of the central bulge
limits its efficacy and only its expression at high levels such
as during viral infection probably renders such interactions
functional.
Isolation of protein complexes involved in TDMD induction
Since it is possible to purify RISC complexes from crude
extract using biotinylated 2’O-methylated oligoribonu-
cleotides (32), we used a similar approach to capture the
TDMD nucleoprotein complexes by transfecting antimiR-
NAs in HeLa cells (Figure 2A). To this end, we used
antimiR-27, m169-like and antimiR-16 2’O-methylated
oligoribonucleotides carrying a triethylene glycol spacer
with a biotin group on the 3′ terminal residue. We first
determined the optimal concentration required to induce
tailing-trimming without extensive degradation of the tar-
geted miRNA, and found that 7.5, 250 and 3 nMwere opti-
mal for biotinylated antimiR-27, m169-like and antimiR-16
respectively. After collection of total cell lysates from trans-
fected cells and incubation with paramagnetic-streptavidin
beads, the analysis of retrievedRNAs revealed specific bind-
ing of miR-27 with both antimiR-27 and m169-like (Fig-
ure 2B,C) as well as miR-16 with its corresponding an-
timiRNA (Figure 2D). No signal was detected in non-
transfected cells (beads) or cells transfected with a control
oligoribonucleotide (control = antimiR-67). More impor-
tantly, we could also detect tailed and trimmedmiRNA iso-
forms with this method.
We then increased the scale of the experiment and an-
alyzed the bound proteins by nanoLC-MS/MS. The data
were filtered to consider only proteins specifically bound to
the antimiRNAs and not to the control oligoribonucleotide
or to the beads (Supplementary Figure S2A–C). Among
the factors identified, we could retrieve known components
of RISC complexes such as AGO1, 2 and 3, TNRC6B,
and RBM4 (Figure 2E). We also identified exoribonucle-
ases such as XRN2 or the 3′-5′ exonuclease DIS3L2, re-
cently shown to be involved in mRNA and let-7 precursor
decay (11,33) with the three capture-oligoribonucleotides.
Finally, the Terminal-Uridylyl-Transferase (TUT)-1 (Star-
PAP/RBM21) was pulled-down specifically with antimiR-
27 in our two replicates, albeit at relatively low levels.
To increase the confidence in ourmass spectrometry anal-
ysis, we performed additional replicate experiments (up to
five with the antimiR-27) and decided to focus on proteins
that were present in at least three of the replicates, while
being absent in their respective negative control experi-
ments (control oligoribonucleotide or beads alone) (Supple-
mentary Table S1). This allowed us to significantly reduce
the number of false positives and to narrow down the list
of putative candidates. With this approach, we found that
DIS3L2 was reproducibly pulled-down both with antimiR-
27 and antimiR-16. This enzyme belongs to the Dis3 fam-
ily together with two other homologs, DIS3 and DIS3L but
with the difference that it is not associatedwith theRNA ex-
osome. It is a highly processive enzyme, also capable of de-
grading dsRNAwith little (2 nt) or no 3′ overhangs (33,34).
More interestingly, DIS3L2 was also detectable with m169-
like oligoribonucleotide only when it was transfected at 250
nM (Figure 2E, R1), a concentration that triggers TDMD.
This re-enforces the idea that DIS3L2 is specifically re-
cruited for miRNA trimming.
The replicate experiments also confirmed that TUT1 was
only retrieved with the antimiR-27 oligonucleotide. How-
ever, it was the only of the seven human TUTases to be
identified in our mass spectrometry analysis. This enzyme
belongs to the family of ribonucleotidyl transferases known
among others to contribute to miRNA 3′ heterogeneity (35)
and it possesses both a non canonical poly(A) polymerase
and a terminal uridylyl transferase activities (36–38).
We then confirmed that DIS3L2 and TUT1 could indeed
be detected in our pull-down experiments. Western blot
analysis of proteins bound to antimiR-27 revealed a spe-
cific binding of both proteins, as well as of AGO2 (Figure
3A). Similarly, both DIS3L2 and AGO2 could also be de-
tected by western blot associated to m169-like or antimiR-
16 oligoribonucleotides (Figure 3B,C). The comparative
analysis of proteins and RNA bound to antimiR-27 and
m169-like oligoribonucleotides, when the two biotinylated-
oligoribonucleotides are transfected at similar amounts,
shows they both associate with similar amounts of miR-27
and are equally bound by RISC as assessed by the pres-
ence of AGO2 (Figure 3D). On the contrary, TUT1 and
DIS3L2 are only associated with antimiR-27, the sole target
capable to trigger TDMD at this concentration. Similarly,
even though TUT1 was not found associated to antimiR-
16 in the mass spectrometry data, we managed to detect
it by western blot analysis when we increased the concen-
tration of the oligoribonucleotide (Figure 3E). Under these
conditions, we could also pull-down with both antimiR-
27 and antimiR-16 oligonucleotides the AGO1 protein and
TNRC6B, a GW182 family member essential for miRNA-
mediated gene silencing (39) (Figure 3F).
We also tested the possibility of retrieving other related
enzymes with antimiR-27 or antimiR-16 oligonucleotides
even if we never or rarely detected them in our MS anal-
ysis. For this purpose, we tested the 5′-3′ exoribonucleases
XRN1 and XRN2 (40), the exosome components EXOSC3
(RRP40), RRP6 and DIS3 (41), and finally TUT7 (ZC-
CHC6), which was recently shown to participate to ma-
ture miRNA mono-uridylation (42). None of these pro-
teins were found specifically associated with antimiR-27
and antimiR-16 after TDMD induction (Supplementary
Figure S3). Only XRN2 andDIS3 were detectable but with-
out any specificity for TDMD since they both co-purified
equally well with our control oligoribonucleotide.
Altogether, these results indicate that DIS3L2 and TUT1
are good candidates for TDMD. We thus decided to pro-
ceed with their functional characterization.
TDMD is induced in the RISC complex and occurs in the
cytoplasm
We first sought to answer the question of how the mech-
anism is initiated. TDMD depends on a high degree of
complementarity between the miRNA and its target, rais-
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Figure 2. Identification of the cellular factors involved in TDMD. (A) Schematic representation of the biochemical approach to induce and capture the
factors involved in TDMD. (B–D) HeLa cells were transfected with antimiRNA at a concentration inducing miR-27 or miR-16 TDMD. The complexes
bound to antimiRNA were pulled-down using streptavidin-beads. The specific pull-down of miR-27 and miR-16 using antimiR-27 (replicate R1) (B),
m169-like (C) and antimiR-16 (D) was verified by northern blot. A dashed line indicates discontinuous lanes but Input and IP fractions were systemati-
cally analyzed on a same gel. (E) Table showing the number of spectral counts detected by nanoLC-MS/MS for the indicated proteins found specifically
associated with each antimiRNA. The concentration of antimiRNA used in each replicate is indicated in parentheses. Control: antimiR-67.
ing the possibility that the miRNA tailing and trimming is
induced within the RISC. Alternatively, the miRNA could
also be marked for degradation after its release from the
AGO protein.We therefore analyzed small RNAs by north-
ern blot after AGO2 immunoprecipitation, which allowed
us to show that the RISC effector interacted not only with
the major isoforms, but also with tailed and trimmed iso-
forms of miR-27 when TDMD is induced (Figure 4A). The
tailed and trimmed isoforms detectable by northern blot
were comprised between 16 and 26 nucleotides in length
(Supplementary Figure S4A). Similar results were obtained
with miR-16 (Supplementary Figure S4B) or when miR-
27 TDMD was induced by transient expression of a piece
of the m169 transcript (Supplementary Figure S4C). Thus,
although it is unclear whether the miRNA undergoing
TDMD is eventually ejected from RISC, both tailing and
trimming of miRNA seem to occur, at least partially, within
AGO2.
More importantly, these observations suggest that both
TUT1 and DIS3L2 might be recruited to the RISC. To
test this hypothesis, we performed co-immunoprecipitation
of DIS3L2, TUT1 and AGO2 after transfection of HeLa
cells with plasmids expressing tagged-versions of the pro-
teins. We observed that both TUT1 and DIS3L2 interact
with AGO2 (Figure 4B,C) but also together (Figure 4D).
These interactions are RNA-mediated (putatively miRNA-
mediated), since they were sensitive to RNaseA treatment
(Figure 4B–D). So, TUT1, DIS3L2 and AGO2 seem to be
part of the same complex even if it is probably transient
since target-induced miRNA decay is not a predominant
mechanism.
The previous results raise the question of the formation
of a complex comprising AGO2, DIS3L2 and TUT1, since
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Figure 3. AntimiRNAs associate with DIS3L2, TUT1 and RISC components. (A–C) The presence of AGO2, DIS3L2 and TUT1 with antimiR-27 (A),
m169-like (B) or antimiR-16 (C) was confirmed by western blot. (D) Comparative analysis of DIS3L2, TUT1, AGO2 and miR-27 pulled-down with
antimiR-27 or m169-like oligonucleotides at 10 nM. (E) TUT1 and DIS3L2 detection after pull-down of antimiR-27 and antimiR-16 both transfected at
10 nM to induce TDMD. (F) AGO1 and TNRC6B are also associated with antimiR-27 and antimiR-16 both transfected at 10 nM. A dashed line indicates
discontinuous lanes but Input and IP fractions were systematically analyzed on a same gel (A-F). Control: antimiR-67.
TDMD is most likely to occur in the cytoplasm and ear-
lier reports showed that TUT1 was a nuclear protein (37).
However, recent work indicates that this might not be its
sole localization, as it could be observed both in the nu-
cleus and the cytoplasm (43). We thus wanted to verify the
relative amount of TUT1 in the cytoplasm and in the nu-
cleus in our experimental setup, and to confirm that the
cytoplasmic TUT1 interacts with DIS3L2 and AGO2. We
therefore performed a subcellular fractionation and ana-
lyzed the distribution of the different proteins (Figure 4E).
Using tubulin as a cytoplasmic marker and histone H3 as
a nuclear marker, we found that DIS3L2 was only present
in the cytoplasm as expected (33,34), similar to TUT7 (27),
AGO2 could be observed in both compartments, as previ-
ously reported (44), and we also found TUT1 both in the
cytoplasm and the nucleus (Figure 4E) confirming that this
TUTase is indeed a nucleo-cytoplasmic protein. We then
immunoprecipitated TUT1 from a cytoplasmic extract and
could observe that it interacted with endogenous DIS3L2
and AGO2, thereby confirming that these interactions nat-
urally occur in the cytoplasm (Figure 4F).
We showed earlier that DIS3L2 and TUT1 could be
pulled-down with the antimiRNA oligoribonucleotide only
under conditions where TDMD was induced (Figure 3D).
We therefore looked whether we could confirm the inter-
action by immunoprecipitating the proteins and detecting
the miRNA. For DIS3L2, we used the catalytic mutant be-
cause the wild type protein association with the targeted
RNA would be too transient. The immunoprecipitation of
DIS3L2mut shows that the exonuclease seems to interact
weakly with miR-27 but independently of TDMD (Fig-
ure 4G). DIS3L2 might therefore have additional roles in
miRNA decay that are independent of TDMD. Nonethe-
less, the mutant protein interacted more strongly than
the wild-type exonuclease with tailed/trimmed isoforms of
miR-27 (Supplementary Figure S4D) confirming its role in
miRNA trimming.
Finally, we analyzed small RNAs after immunoprecipi-
tation of TUT1. We confirmed that the pull-down was effi-
cient, since we could retrieve its known substrate U6 (38).
The northern blot analysis also revealed that it exclusively
interacted withmiR-27 isoforms when TDMDwas induced
with antimiR-27 oligonucleotide (Figure 4H). In addition,
we also performed northern blot analysis of miR-27 after
immunoprecipitation of other TUTases (TUT4, TUT7 and
TUT2), but could not detect themiRNA coming downwith
any of these, be it in the presence or not of the antimiRNA
oligonucleotide (Supplementary Figure S4E).
DIS3L2 is implicated in miRNA trimming
We then aimed at validating the involvement of TUT1 and
DIS3L2 in TDMD by performing knockdown experiments
of either each factor separately or both of them together and
we monitored the level of TDMD induced by antimiRNA
transfection. We observed an efficient depletion of these
two factors at the protein level in HeLa cells (Figure 5A).
Nonetheless, the efficiency of TDMDwas not altered as as-
sessed by northern blot analysis of miR-27 (Supplementary
Figure S5A) andmiR-16 (Supplementary Figure S5B) com-
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Figure 4. TDMD is induced in the RISC complex by recruitment of TUT1 andDIS3L2. (A) AGO2-associated tailed and trimmed isoforms of miR-27 were
analyzed by northern blot. A space indicates discontinuous lanes from the same gel (also applicable to panels E and F). (B–D) Co-immunoprecipitation
(anti-GFP) experiments show interaction between GFP-TUT1 and HA-AGO2 (B), GFP-DIS3L2 and HA-AGO2 (C) and GFP-DIS3L2 and HA-TUT1
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proteins in the nucleus (nuc) and the cytoplasm (cyto) were analyzed by western blot. TUT7 and Tubulin serve as cytoplasmic markers while Histone H3 is
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on the cytoplasmic fraction. Non-transfected cells (NT) serve as negative control. (G) miR-27 isoforms co-precipitate together with GFP-DIS3L2 mutant.
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a known substrate of TUT1, serves as positive control. A dashed line indicates discontinuous lanes from the same gel (A, E, G, H).
pared to the cells transfected with the control siRNA (siC-
trl).
This result could be explained by the tendency of TU-
Tases to complement each other in vivo (45) and/or the high
processivity ofDIS3L2 (34). To evaluate the contribution of
the other TUTases, we performed multiple knockdowns in
HeLa cells and again tested the efficiency of the TDMD.
To this end, we separated the TUTases in two groups. In
addition to TUT1, the first group (TUT1+2+4+7) com-
prises TUT2 (also called GLD2 and PAPD4), TUT4 (ZC-
CHC11) and TUT7 (ZCCHC6) as they are known to act re-
dundantly in the pre-let-7 mono-uridylation (45). The sec-
ond group (TUT1+3+5+6) is composed of TUT1, TUT3
(PAPD5), TUT5 (PAPD7) and TUT6 (MTPAP). However,
we did not manage to rescue miRNA stability with any of
the two siRNA mixes (data not shown). So, we cannot ex-
clude that other combinations of TUTases, or more than
four of them might act redundantly in this process. Simi-
larly, we also tried to knockdown other exoribonucleases
such as XRN1 and XRN2 alone or in combination with
DIS3L2, but again could not observe an effect on miR-27
degradation induced by antimiRNA oligonucleotides (data
not shown).
It could also be that the northern blot analysis approach
we used to measure the effect of TUT1 and DIS3L2 knock-
downs on miRNA levels presents limitations when it comes
to assess subtle differences. We thus decided to perform
small RNA cloning and sequencing in order to verify if
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trimmed versusWT (‘0’ or mature sequence) reads after TDMD induction (antimiR-27) normalized to those observed without TDMD (antimiR-67) using
the values shown in C. The values were arbitrarily set at 1 in cells transfected with the control siRNA (siCtrl). (E) The efficiency of the tailing in each
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some changes that could not be observed by other means
occur after TUT1 and/or DIS3L2 depletion. We first mon-
itored the impact of antimiR-27 transfection onmiR-27 iso-
forms, which allowed us to see that themost abundant tailed
isoforms of miR-27a present an addition of one or two U
residues at their 3′ end (Figure 5B). We could also detect a
low number of miR-27 sequences presenting additional A
residues, or a mix of A and U residues (data not shown).
We calculated the respective abundance of the most abun-
dant isoforms ofmiR-27a (in percentage relative to the total
number of miR-27a in each sample) in presence or absence
of TDMD induction by antimiR-27 and we observed an in-
crease in the abundance of tailed and trimmed isoforms and
a decrease of the major isoforms of miR-27a or b in pres-
ence of the antimiR-27 (respectively in green and in red in
Figure 5B).
We then determined more precisely the distribution of
miR-27a isoforms in libraries generated from cells treated
with a control siRNA or siRNAs directed against TUT1,
DIS3L2 or both and transfectedwith an antimiR-27 or con-
trol (antimiR-67) oligonucleotide. For each library, we cal-
culated the number of wild-type (after miRBase) sequences
of miR-27a that we set as the ‘0’ modification, as well
as the number of sequences tailed or trimmed by 1, 2 or
more nucleotides (respectively +1, +2. . . and −1, −2. . . ).
The deep-sequencing analysis confirmed that miR-27a ex-
ists mainly as three isoforms of 21 (0), 20 (−1) and 22 (+1)
nucleotides. We therefore considered as trimmed and tailed
sequences, all isoforms presenting with an addition or dele-
tion of more than 2 nucleotides. As shown in Figure 5C for
miR-27a, in cells treated with the control siRNA the per-
centage of trimmed sequences indeed increased in the pres-
ence of antimiR-27 (bottom graph) compared to antimiR-
67 (top graph). We also observed a modest increase in
tailing upon transfection of the specific antimiRNA. This
increase in trimming seems to be less pronounced when
DIS3L2, TUT1 or both DIS3L2 and TUT1 were knocked-
down (Figure 5C and Supplementary Figure S5C). We did
the same calculation for miR-27b and roughly observed the
same effects, although less pronounced, which might be due
to the fact that the antimiRNA oligonucleotide we trans-
fected was directed against miR-27a (Supplementary Fig-
ure S6).
To quantify these differences, we then calculated the effi-
ciency of trimming (Figure 5D) and tailing (Figure 5E) in
each knockdown condition and for bothmiR-27a andmiR-
27b. To this end, we first determined the ratio of trimmed
(or tailed) to wild-type (mature) sequences in antimiR-27
versus antimiR-67 in each condition, and then normalized
it to the ratio found in the control cells, which was arbi-
trarily set to 1. TUT1 depletion did not seem to affect the
efficiency of trimming of both miR-27a and b (Figure 5D
and Supplementary Figure S5C). However, we observed a
40–50% reduction in trimming of miR-27a and b in cells
where DIS3L2 or DIS3L2 and TUT1 were knocked-down
(Figure 5D). The effect on tailing was more difficult to as-
sess given the weaker induction of tailingmeasured by deep-
sequencing. The extent of tailing appeared to be quite lim-
ited and did not expend much further than 2 nt at most.
This might be due to the timing at which the RNA was iso-
lated after TDMD induction, and that was a bit too late to
fully capture tailed miRNAs. Alternatively, it might also be
explained by the experimental procedure used for the small
RNA library preparation and by a sub-optimal size selec-
tion of the PCR products prior to their sequencing. Never-
theless, it seems that TUT1 knock-down had no effect on
tailing, while DIS3L2 or DIS3L2 and TUT1 knock-down
had a mild negative impact (Figure 5E).
Overexpression of a catalytic mutant of DIS3L2 impairs
TDMD
To further prove the involvement of DIS3L2 in the mech-
anism, we also used another strategy consisting in the ex-
pression of a catalytically inactive mutant protein. Indeed,
knockdown by siRNA will never achieve a complete re-
moval of the targeted protein, and the remaining DIS3L2
might still be capable of degrading its substrate RNA.
The mutant DIS3L2 (DIS3L2mut) was therefore generated
by replacing two residues from the catalytic site (D391N,
D392N), a mutation known to affect DIS3L2 activity with-
out impairing its ability to bindRNA (34,46).We then over-
expressed HA-DIS3L2, HA-DIS3L3mut or an empty plas-
mid (pcDNA) in HEK293 cells and induced TDMD by
transfection of antimiRNA oligonucleotides.
We first verified that the mutation in DIS3L2 did not af-
fect its expression (Figure 6A). TheRNA samples were then
analyzed by northern blot and wemeasured the fold change
accumulation of the targeted miRNAs. If we were expect-
ing that the over-accumulation of HA-DIS3L2would either
stimulate TDMD or induces a dominant negative effect, its
overexpression did not alter the efficiency of the TDMD of
miR-27 compared to the control (Figure 6B). This might be
due to the fact that the activity of the endogenous DIS3L2
was already at saturating level. On the contrary, the over-
expression of DIS3L2mut led to a stabilization of miR-27
isoforms most likely due to a dominant negative effect (Fig-
ure 6B). This effect was reproducibly observed and resulted
on average in amild but significant 1.5-fold increase inmiR-
27 level (Figure 6B). A similar stabilizationwas observed for
miR-16, as transfection ofDIS3L2mut impairedTDMDon
this miRNA as well (Figure 6C). Thus, this result confirms
the involvement of DIS3L2 in TDMD.
We have shown previously thatMCMVdegrades endoge-
nous miR-27 via the viral transcript m169 (20). We there-
fore wanted to test whether DIS3L2 could also be involved
in TDMD naturally induced by this virus. We infected
cells transiently overexpressing the mouse (m)DIS3L2 or
its catalytic mutant with MCMV and investigated the im-
pact on miR-27 accumulation. Both HA-mDIS3L2 and
HA-mDIS3L2mut were expressed at similar levels (Fig-
ure 6D). The levels of miR-27 (Figure 6E) and of the vi-
ral transcript m169 (Figure 6F) were monitored by qRT-
PCR at different time points of infection and in three in-
dependent experiments. We first observed that the over-
expression of mDIS3L2 does not globally impact miR-27
degradation compared to the control cells expressing the
empty vector (Figure 6E, HA-mDIS3L2 versus pcDNA)
as observed in human cells. We have only a slight en-
hancement of miR-27 degradation at 8 hpi, but this effect
seems to disappear over time. On the contrary, we could
observe a mild but significant stabilization of miR-27 in
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Figure 6. Overexpression of a catalytic mutant DIS3L2 inhibits TDMD. (A) Expression levels of HA-DIS3L2 and HA-DIS3L2mut in HEK293 cells by
western blot. Tubulin serves as loading control. (B) miR-27 degradation is inhibited in HEK293 cells overexpressing the catalytically inactive version of
DIS3L2 (DIS3L2mut) as shown by northern blot and after quantification. A dashed line indicates discontinuous lanes from the same gel. The bar graph
shows the quantification of miR-27 fold change normalized to the empty vector (pcDNA), which was arbitrarily set to 1. Error bars indicate SDs (Student
t-test: *P < 0.05, n = 4 biological replicates). (C) Same analysis as in (B), but for miR-16 degradation. (D) Expression levels of HA-mDIS3L2 and HA-
mDIS3L2mut by western blot at 48 hpi. Ponceau S staining serves as loading control. (E) MiR-27 accumulation was monitored in mouse Hepa 1.6 cells
during a time course of infection by the MCMV. Prior to infection, Hepa 1.6 cells were transfected with an empty plasmid (black), a plasmid coding for
HA-mDIS3L2 (light blue) or HA-mDIS3L2mut (dark blue). The graph represents the relative miR-27 levels measured by qRT-PCR at 0, 8, 24 and 48 hpi.
MiR-27 levels were normalized to those of miR-24 which serves as reference and arbitrarily set at 1 at 0 hpi for each condition. Error bars indicate SDs
performed on three independent experiments. (Student t-test *P < 0.05, **P < 0.01, ***P < 0.001; n = 3 biological replicates). (F) The level of the viral
m169 transcript was measured by qRT-PCR in the samples used in (E) at 8, 24 and 48 hpi. The transcript coding for PPIA (Peptidylprolyl isomerase A)
was used as reference. For each time point, the expression of m169 transcript in HA-mDIS3L2 and HA-mDIS3L2mut expressing cells was normalized to
the samples containing the empty vector (pcDNA) which was set at 1.
cells expressingmDIS3L2mut compared to cells transfected
with mDIS3L2 or empty pcDNA at 8 and 48 hpi (Fig-
ure 6E; HA-mDIS3L2mut versus HA-mDIS3L2 and HA-
mDIS3L2mut versus pcDNA).
This stabilization was confirmed by northern blot (Sup-
plementary Figure S7), which allowed us to visualize the
different isomiRs, when the qRT-PCR only measures the
abundance of the whole population of a given miRNA. In-
deed, we could observe a stronger accumulation of the ma-
jor isoforms of miR-27 in the presence of mDIS3L2mut
at 48 hpi. To verify that this difference was not solely due
to a defect in the infection efficiency, or in the production
of the m169 transcript, we measured its accumulation by
qRT-PCR in the experiments described above. This tran-
script starts to be expressed 2–3 h after infection (20), we
thus arbitrarily decided to normalize its relative expression
to the 8 hpi time point (and not 0 hpi) as we are sure that
the signal detected is due to de novo synthesis of the m169
transcript. As shown in Figure 6F, we could appreciate that
m169 transcript accumulates at similar level in cells express-
ing mDIS3L2 and mDIS3L2mut, no significant differences
were observed. Thus, the differential accumulation of miR-
27 in those cells are only due to the overexpression or not,
of the inactive form of mDIS3L2. Taken together, these re-
sults indicate that DIS3L2 is also involved in TDMD when
this mechanism is naturally induced by MCMV.
DISCUSSION
The stability and function of a miRNA is tightly linked to
its interaction with other RNAmolecules. Thus, it has been
demonstrated that it was possible to prevent miRNA load-
ing into the RISC by the use of artificial decoy or sponge
RNAs (47). This observation was later confirmed to natu-
rally exist with the discovery of circular RNAs that can titer
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miRNAs such as miR-7 (48). Pairing with its RNA target
will usually result in the stabilization of the miRNA (49),
a mechanism that has been referred to as target-mediated
miRNA protection. However, in other cases, the miRNA-
target pairing can have the opposite effect and lead to the
miRNA decay via the TDMD mechanism we studied here.
In addition to the MCMVm169 transcript, the herpesvirus
saimiri HSUR RNA can also target miR-27 for degrada-
tion (22). Similarly, the human cytomegalovirus encodes a
bicistronic mRNA that triggers degradation of the cellu-
lar miRNA family miR-17/miR-20a (50). The molecular
mechanisms at play in this particular mode of regulation
have not been elucidated to date.
We confirmed here previous observations (23,24) that
showed that TDMD is governed by themiRNA/target ratio
as well as the degree of complementarity. Nevertheless, we
also observed that TDMD operates in a non-cooperative
manner in contrast to the classical miRNA-mediated tar-
get regulation. The cellular factors implicated in this par-
ticular miRNA decay mechanism were not known. Using
a powerful proteomic approach, we characterized the pro-
tein complexes involved in miRNA tailing and trimming.
Among the proteins we identified, we focused our analy-
sis on two promising candidates: TUT1 and DIS3L2. As
opposed to other TUTases, TUT1 had never been impli-
cated in miRNA biogenesis. In addition, the most studied
nucleotidyl transferases TUT4 and TUT7 act at the pri- or
pre-miRNA level and never on the mature miRNA (51). In
plants, the HESO1 protein has been implicated in uridyla-
tion of unmethylated miRNAs (52), but multiple terminal
nucleotidyl transferases are required for this process to be
fully active, including uncharacterized ones (53).
We did not manage to functionally implicate TUT1 in
TDMD in our conditions, which might also indicate that
this is a complicated synergistic process. Nonetheless, we
could confirm the interaction between TUT1 and AGO2.
We also show here that TUT1 interacts with tailed and
trimmed isoforms of miR-27 only when TDMD is induced.
In addition we also retrieved peptides for the SART3 pro-
tein in our mass spectrometry analysis (Supplementary Ta-
ble S1). SART3, also known as Tip110, associates with U6
snRNP (54) and has been recently confirmed to interact
directly with the C. elegans homolog of TUT1, USIP1, to
participate in U6 snRNA recycling (55). Most importantly,
it has been identified as a direct interactor of both AGO1
and AGO2 in HEK293 cells (56). Therefore, we have a link
explaining how TUT1 could be recruited to AGO2 when
TDMD is induced. This also confirms that both TUT1 and
SART3 must interact with AGO proteins in the cytoplasm,
as we could show for TUT1 and AGO2. Our results also in-
dicate that TUT1 might not bind with the same efficiency
to all miRNAs, since we could only retrieve it by mass spec-
trometry with antimiR-27 oligonucleotides, and its associ-
ation with miR-16 seemed to be much weaker. Recently, it
was demonstrated that TUT4 (ZCCHC11) and TUT7 (ZC-
CHC6) selectivelymono-uridylate a subset of miRNAs har-
boring a specific motif (42). This observation strongly sug-
gests that similar specificity for given miRNAs will govern
the choice of TUTases recruited for the TDMD of other
miRNAs. More work will be needed to definitely know
which of the seven TUTases are involved in TDMD.
Our results are more conclusive when it comes to the
other factor involved in TDMD. Indeed, we could func-
tionally implicate DIS3L2 in this process both using knock-
down followed by small RNA sequencing analysis and over-
expression of a catalytic mutant showing a dominant nega-
tive effect. We did not manage to fully restore miRNA sta-
bility, which might either indicate that other enzymes could
be implicated or that the high processivity ofDIS3L2makes
it difficult to fully inactivate it be it by RNAi or overexpres-
sion of a dominant negative mutant.
It could also be that DIS3L2 would only be involved in
the degradation of miR-27 presenting with additional U
residues, as it was shown to preferentially target U-tailed
substrates (46). The recently obtained crystal structure of
DIS3L2 revealed that it could accommodate an artificial 12-
mer oligonucleotides solely composed of Us (57), but our
sequencing analysis revealed that the vast majority of miR-
27 sequences appear to present with only few additional U
residues at their 3′ extremity. In addition, a few sequences
also had A residues. So, DIS3L2 might also be active on
short RNAs presenting as little as two Us and/or As. This
is in agreement with characterization of its in vitro activity,
which indicates that the enzyme can target sequences with
overhanging As (34).
Alternatively, miRNAs presenting A additions might be
degraded by another enzyme. In that respect, miR-27a was
shown to be adenylated by PAPD4 (TUT2), but this did not
seem to affect its stability (58). Similarly, PAPD5 (TUT3)
was also implicated in the adenylation of other miRNAs,
such as miR-21, and in this case this resulted in its degra-
dation by PARN (59). To verify that the enzymes that
were studied in these two reports had no impact on miR-
27a and b, we reanalyzed the small RNA libraries that
were generated in these manuscripts, but did not find ev-
idence of differential accumulation, or of an impact on
the tailed and trimmed forms of these miRNAs (data not
shown). Altogether our results therefore allowed us to iden-
tify DIS3L2 as the exoribonuclease involved in one specific
mature miRNA degradation pathway.
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